Servier Research and Pharmaceuticals Pakistan during their Annual Sales Conference recently at Bhurban gave another breakthrough in diabetes management with the launch of Diamicron MR 60mg.
An exclusive and detailed two days training was arranged for field force to equip them with the latest developments in Diabetes Care and the added benefits Diamicron MR 60mg offering in the management of diabetes.
On this occasion Prof. Javed Akram, Principle, Allam Iqbal Medical College Lahore graced the occasion with his expert views to Servier’s team on latest developments in Diabetes management and the current challenges in diabetes care. He appreciated the Servier International Research and Pharmaceuticals for the development of Diamicron MR 60mg, a first breakable modified release formulation and commented the Diamicron MR 60mg would be a step forward by providing better compliance to type 2 diabetic patients.
Diabetes represents a key therapeutic area for Servier through a long-term cooperation with the major International Diabetes Associations, helping to improve diabetes care for millions of patients worldwide.
Servier Research Group has been a major partner in the field of Diabetology through a continuous support of the most important scientific bodies like European Foundation for the Study of Diabetes (EFSD), Mediterranean Group for the Study of Diabetes (GSD), International Group of Insulin Secretion (IGIS) and Diabetes Education Study Group (DESG).
As a global metabolic and vascular treatment, Diamicron MR thanks to unique antioxidant properties, restores physiological insulin secretion, tightly controls blood glucose over the short and long term, and provides direct cardiovascular protection.
Servier Pakistan launched diabetes care range with Diamicron in 1981 and was a breakthrough by reducing the risk of hypoglycemia in Type 2 Diabetes patients. Diamicron enjoyed leadership in diabetes management for almost a decade.
Apart from efficacy of a drug patient’s compliance with the treatment is very important in diabetic patients and Servier by again gave a breakthrough in 2001 by launching first modifies release formulation (Diamicron MR) in oral antidiabetics. In Advance that was the ever largest trial in Type 2 Diabetic patients Diamicron MR was used.
The launch of Diamicron MR 60mg is a landmark event in the pharmaceutical industry; especially in diabetes market and have the fantastic opportunity to the part of the launch.
Diamicron MR 60mg is a long awaited medical need of patients requested by doctors all over Pakistan. Keeping in view its potential that is no doubt that Diamicron MR 60mg is a blockbuster product because it addresses the core need of patient
For powerful, rapid and Sustained blood glucose control with convenience dosage with protection from serious complications.
In the context of a favorable medical environment (the constant growth of Type 2 Diabetes and the endorsement by the new international guidelines re-evaluating the role of the well-established treatments such as Diamicron MR 60mg), the main ADVANCE results and new data represent a fantastic opportunity more than ever.
The new data demonstrated that Diamicron MR 60mg is always the right choice—a cornerstone treatment—thanks to efficient and safe glycemic control in all clinical settings (whatever the previous treatments and patient profile).